Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. [electronic resource]
Producer: 20050110Description: 227-39 p. digitalISSN:- 1524-4539
- Aged
- Anticholesteremic Agents -- therapeutic use
- Antihypertensive Agents -- therapeutic use
- Cardiovascular Diseases -- epidemiology
- Cholesterol, LDL -- blood
- Clinical Trials as Topic -- statistics & numerical data
- Comorbidity
- Diabetes Mellitus -- epidemiology
- Evidence-Based Medicine
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Hypercholesterolemia -- epidemiology
- Hypertension -- drug therapy
- Hypolipidemic Agents -- therapeutic use
- Middle Aged
- Myocardial Infarction -- drug therapy
- Patient Education as Topic
- Practice Guidelines as Topic
- Randomized Controlled Trials as Topic -- statistics & numerical data
- Risk
- Risk Factors
- Thrombolytic Therapy
No physical items for this record
Publication Type: Consensus Development Conference; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.